Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed that the management of the Company shall be meeting analysts/investors through NBIE Virtual Investor Meeting hosted by Nirmal Bang Institutional Equities on 25th November, 2022.
The above information is a part of company’s filings submitted to BSE.